Category: Private Citizen — Corporate Director Role: Independent Director, UnitedHealth Group Inc. (UNH); Health and Clinical Practice Committee Chair Board Tenure: 2017 – present Committee Memberships: Health and Clinical Practice Policies Committee (Chair); Compensation and Human Resources Committee Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)

Basis for Inclusion: Dr. Valerie Montgomery Rice holds a documented governance role as Chair of the Health and Clinical Practice Policies Committee at UnitedHealth Group Inc., which made documented political donations to Trump-aligned entities. As chair of the committee that oversees UnitedHealth’s medical practice standards and coverage policies, Montgomery Rice holds board-level responsibility for the clinical practices that have been at the center of congressional and regulatory scrutiny — including prior authorization policies, denials of coverage, and the use of AI-driven claims review. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Director. Board membership is a matter of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.

Biographical Overview

Valerie Montgomery Rice, M.D. is President and CEO of Morehouse School of Medicine in Atlanta, Georgia, a position she has held since 2011. She is a gynecologist and infertility specialist who also conducts research on environmental and health disparities affecting women’s reproductive health. Before Morehouse, she was Dean of Medical Education and Research at Meharry Medical College. She is widely recognized as one of the most prominent Black women in academic medicine in the United States.

Montgomery Rice chairs UnitedHealth’s Health and Clinical Practice Policies Committee — the board committee responsible for overseeing the company’s medical management policies, quality standards, and clinical practice guidelines. Given the intense scrutiny UnitedHealth has faced regarding prior authorization denials and AI-driven claims review, this governance role carries particular accountability significance.

She holds an M.D. from Howard University College of Medicine and an undergraduate degree from Spelman College.

Board Role and Governance Authority

• Company: UnitedHealth Group Inc. (NYSE: UNH)
• Board tenure: 2017 – present
• Committee assignments: Health and Clinical Practice Policies Committee (Chair); Compensation and Human Resources Committee
• Day job: President & CEO, Morehouse School of Medicine

Parent Corporate Donor Profile

This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

• UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766)